Asia Pacific Vascular Closure Devices Market is expected to be valued at USD 4.4
Posted by rohan on October 4th, 2018
Vascular closure devices (VCDs) are scientific devices used to obtain vascular hemostasis after the puncture of the femoral artery at some point of diagnostic angiography methods or interventional strategies. VCDs are developed as an opportunity for mechanical compression. Although mechanical compression is a powerful method for the treatment of hemostasis, it takes a prolonged term to effectively obtain hemostasis than vascular closure gadgets.
According to the article published by world health organization (WHO) in 2017, approximately 17.7 million human beings died from cardiovascular sicknesses in 2015, which is about 31% of all global deaths. Among them, round 7.4 million died due to coronary heart sickness and 6.7 million have been due to stroke.
The Asia-Pacific Vascular Closure devices market changed into well worth USD 1.79 billion in 2018 and is predicted to be developing at a CAGR of 9.5%, to attain USD 4.42 billion by 2023.
Drivers and Restraints:
The vascular closure devices market is majorly driven through the excessive occurrence of cardiovascular illnesses, a high occurrence of obesity and the growing need for minimally invasive strategies. moreover, factors together with growing approvals for vascular closure devices, authorities tasks, and useful resource, rising demand for advanced treatment, growing studies and medical trials for vascular closure devices and growing market players presenting extra present day merchandise are in all likelihood to power the market.
As an alternative, the excessive cost of vascular closure devices, product recalls, and failures, and lack of skilled expert humans are impeding the growth of the market.
Asia-Pacific vascular closure devices market is classified into China, India, Japan, Australia, and South Korea. The VCDs marketplace in this vicinity is swiftly growing due to rise in expenditure on healthcare in countries like China and India, massive patient base and growing cardiovascular sicknesses.
The key players of the market include W L. Gore & Associates, Merit Medical Systems, Inc., Abbott Vascular, Biotronik GMBH & CO.KG, St. Jude Medical, Cardinal Health, Medtronic, Boston Scientific Corporation, Cardival Medical, Inc., Essential Medical, Inc., TZ Medical, Inc. and Scion BioMedical.
Scope of the report
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Like it? Share it!
About the Authorrohan
Joined: September 20th, 2017
Articles Posted: 1,346
More by this author